Balanced news tone
News Sentiment
1J5 sentiment intelligence
Hyphens Pharma International Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +6.1% over four weeks, trend active, and near fair-value range.
kopi-C with CEO of Hyphens Pharma International: From dispensary to ASEAN's dermatology specialist
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
kopi-C with CEO of Hyphens Pharma International: From dispensary to ASEAN's dermatology specialist
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Beansprout
Hyphens Pharma grants Swiss pharma company rights to commercialise Cerapro MED Skin Barrier Cream
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jan 2026 08:00
- Source
- Market source
Hyphens Pharma earnings down 66.3% y-o-y for 1HFY2025 to $1.9 mil
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Aug 2025 07:00
- Source
- Market source
Ardence Pharma deal favourable, analysts keep 'buy' on Hyphens Pharma
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 23 Oct 2023 07:00
- Source
- The Edge Singapore
Hyphens Pharma to acquire remaining 58% of shares in Ardence Pharma, making it a wholly-owned subsidiary
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Oct 2023 07:00
- Source
- The Edge Singapore
6 Things Investors should know about Hyphens Pharma (SGX: 1J5)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2022 07:00
- Source
- SmallCapAsia
Hyphens Pharma inks exclusive licensing deal with Favorex to commercialise biosimilar in Singapore, Malaysia, Philippines
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 Dec 2021 08:00
- Source
- The Business Times
Hyphens Pharma to acquire Novem companies for S$16.3 million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Nov 2021 08:00
- Source
- The Business Times
Hyphens Pharma launches Ceradan Advanced
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2019 07:00
- Source
- Market source
Hyphens Pharma rises on Catalist trading debut
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2018 07:00
- Source
- The Straits Times